When you need to make the best treatment decisions for your patients, where do you turn to find information on drugs when you want to be sure the information hasn’t been influenced by the pharmaceutical industry? Himmelfarb Library provides access to two great options: The Medical Letter and Drugs of Choice!
The Medical Letter
The Medical Letter on Drugs and Therapeutics has a long history of being among the most used journal titles in Himmelfarb’s journal collection and is a trusted source for critical appraisals of new drugs and comparative reviews of drugs used to treat common diseases. Busy healthcare professionals don’t always have the time or resources to research manufacturers’ or pharmaceutical companies’ claims about a drug. The Medical Letter, a non-profit organization that is subscription funded, provides unbiased, reliable, and timely drug information that has been reviewed by medical experts who have come to an unbiased consensus.
Whether you want to find out if a new prescription drug has advantages over older drugs, learn about the drug's effectiveness, and toxicity issues, or learn if the drug price is reasonable enough to justify prescribing it to patients, The Medial Letter has the information you need! Follow-up reports highlight any new information that may have changed the status of previously reviewed drugs, so you can be sure you are getting the most updated information. Himmelfarb’s subscription to The Medial Letter provides access to continuing education credits. You can also download the mobile app to access The Medical Letter from your mobile device.
Drugs of Choice
The Drugs of Choice 2022 Handbook provides updated information on preferred and alternative treatments for conditions such as alcohol use disorder, multiple sclerosis, onychomycosis, Parkinson’s disease, rheumatoid arthritis, heart failure, and more. There is even information on topics such as insect repellents and sunscreens. Drugs of Choice is a definitive guide for finding:
- Recommendations for first-line and alternative drugs
- Potential Adverse Effects
- Dosing Recommendations
- Risk of Drug Interactions
- Use in Pregnancy
Information is presented in easy-to-read tables, making this resource handy for quick reference.
The Medical Letter and Drug of Choice are both key resources that provide quick, easy-to-use tools to get the information you need to stay updated with the latest drug information! For more information or if you have questions about Himmelfarb’s access to these resources, contact Ruth Bueter (rbueter@gwu.edu).
